Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 1—January 2007

Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization

Rebecca H. Sunenshine*, Marc-Oliver Wright†, Lisa L. Maragakis‡, Anthony D. Harris†, Xiaoyan Song‡, Joan Hebden†, Sara E. Cosgrove‡, Ashley Anderson*, Jennifer Carnell*, Daniel B. Jernigan*, David G. Kleinbaum*, Trish M. Perl‡, Harold C. Standiford†, and Arjun Srinivasan*Comments to Author 
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †University of Maryland Medical School and Medical Center, Baltimore, Maryland, USA; ‡Johns Hopkins University, Baltimore, Maryland, USA;

Main Article

Table 1

Comparison of baseline characteristics of patients with multidrug-resistant (MDR) Acinetobacter infection with those with susceptible Acinetobacter infection and those without Acinetobacter infection, Baltimore hospitals, 2003– 2004*

CharacteristicMDR Acinetobacter, 
n = 96Susceptible Acinetobacter, 
n = 91p values for MDR Acinetobacter vs. susceptible, n = 187Uninfected, 
n = 89p values for MDR Acinetobacter vs. uninfected, n = 185
Median age, y54520.61520.97
Age range, y14–8312–8517–90
Sex, % male67570.78650.96
Mean modified APACHE III score (median)41 (42)36 (33)0.0232 (28)<0.001
Mean Charlson index (median)3.9 (3.0)2.8 (2.0)0.012.5 (2.0)<0.01

*APACHE III, Acute Physiology and Chronic Health Evaluation III.

Main Article

Page created: June 28, 2010
Page updated: June 28, 2010
Page reviewed: June 28, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.